Check Point secures user access control.
- Published in:
- 2018
- By:
- Publication type:
- Product Review
Works matching DE "CHECK Point Software Technologies Ltd."
Results: 37
1
2
Getting to the nitty gritty of identity management.
- Published in:
- ComputerWorld Hong Kong, 2017, p. 32
- By:
- Publication type:
- Article
3
Check Point fortifies endpoint protection.
- Published in:
- ComputerWorld Hong Kong, 2017, p. 32
- By:
- Publication type:
- Article
4
Putting forensic analysis at the endpoint.
- Published in:
- ComputerWorld Hong Kong, 2016, p. 38
- By:
- Publication type:
- Article
5
Keeping the firewall crown.
- Published in:
- ComputerWorld Hong Kong, 2016, p. 37
- By:
- Publication type:
- Article
6
Threat prevention is the new frontier.
- Published in:
- 2015
- By:
- Publication type:
- Product Review
7
Check Point keeps its head in the game.
- Published in:
- 2015
- By:
- Publication type:
- Product Review
8
Software Blade: an edge against intrusion.
- Published in:
- ComputerWorld Hong Kong, 2014, p. 43
- By:
- Publication type:
- Article
9
Eleventh time's the charm.
- Published in:
- ComputerWorld Hong Kong, 2014, p. 42
- Publication type:
- Article
10
Check Point transforms security into a business process.
- Published in:
- ComputerWorld Hong Kong, 2011, v. 28, n. 5, p. 64
- By:
- Publication type:
- Article
11
Check Point: awards for security software and hardware.
- Published in:
- ComputerWorld Hong Kong, 2010, v. 27, n. 5, p. 70
- By:
- Publication type:
- Article
12
Check Point's centralized endpoint security.
- Published in:
- ComputerWorld Hong Kong, 2009, v. 26, n. 5, p. 60
- Publication type:
- Article
13
Centralized security: more control, less hassle.
- Published in:
- ComputerWorld Hong Kong, 2009, v. 26, n. 5, p. 58
- By:
- Publication type:
- Article
14
Check Point: security across the spectrum.
- Published in:
- ComputerWorld Hong Kong, 2008, v. 25, n. 5, p. 48
- By:
- Publication type:
- Article
15
End point security--bolstering front-line defenses.
- Published in:
- 2008
- Publication type:
- Product Review
16
CHECK POINT INHIBITORS IN RELAPSED/REFRACTORY GRAY ZONE LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 714, doi. 10.1002/hon.3165_568
- By:
- Publication type:
- Article
17
Revolutionizing the treatment of cancer using CAR T Cells and Bispecific Antibodies.
- Published in:
- Palestinian Medical & Pharmaceutical Journal, 2025, v. 10, n. 1, p. 1, doi. 10.59049/2790-0231.10.1.2262
- By:
- Publication type:
- Article
18
Acute Gastritis During Immune Check Point Inhibitor Treatment.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2023, v. 6, n. 6, p. 197, doi. 10.1093/jcag/gwab046
- By:
- Publication type:
- Article
19
Penerapan Kerangka Kerja NIST Cybersecurity dan CIS Controls sebagai Manajemen Risiko Keamanan Siber.
- Published in:
- Techno.com, 2023, v. 22, n. 3, p. 527, doi. 10.33633/tc.v22i3.8491
- By:
- Publication type:
- Article
20
Firewalls and Anonymity.
- Published in:
- 2001
- Publication type:
- Product Review
21
Rapidly Progressive Pauci-Immune Glomerulonephritis with Aberrant Fibrinoid Necrosis Associated with Atezolizumab, an Immune Check Point Inhibitor: A Case Report and Review of Literature.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
22
Developing Check-Point Mechanism to Protect Mobile Agent Free-Roaming Against Untrusted Hosts.
- Published in:
- Computers, Materials & Continua, 2022, v. 72, n. 2, p. 3849, doi. 10.32604/cmc.2022.025582
- By:
- Publication type:
- Article
23
CD8+ and FoxP3+ T‐Cell Cellular Density and Spatial Distribution After Programmed Death‐Ligand 1 Check Point Inhibition.
- Published in:
- Laryngoscope, 2023, v. 133, n. 8, p. 1875, doi. 10.1002/lary.30389
- By:
- Publication type:
- Article
24
The Role of Immune Check Point Gene Expression of Pd-1 and Tim-3 in Patients with Acute Myeloid Leukemia.
- Published in:
- Al-Mustansiriyah Journal of Science, 2024, v. 35, n. 1, p. 27, doi. 10.23851/mjs.v35i1.1418
- By:
- Publication type:
- Article
25
342 The Implications of High Expression of VISTA, a Negative Check Point Regulator, on Prognosis Across Malignant Solid Tumors: a Systematic Review and Meta-Analysis.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
26
Flying Watchdog-Based Guard Patrol with Check Point Data Verification.
- Published in:
- Future Internet, 2023, v. 15, n. 10, p. 340, doi. 10.3390/fi15100340
- By:
- Publication type:
- Article
27
Employees Ignoring IT Security.
- Published in:
- Internal Auditor, 2010, v. 67, n. 5, p. 14
- By:
- Publication type:
- Article
28
Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 5, p. 393, doi. 10.3390/jpm11050393
- By:
- Publication type:
- Article
29
The Role of Voluntary Counselling and Testing Points (VCTs) in HIV Diagnostics – Analysis of VCTs Activity in Poland in the Context of Local and European Epidemiology.
- Published in:
- Advancements of Microbiology, 2024, v. 63, n. 3, p. 143, doi. 10.2478/am-2024-0012
- By:
- Publication type:
- Article
30
Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091780
- By:
- Publication type:
- Article
31
Legal Corner: CHECK POINTS: Some “to the point” items to ensure compliance with new requirements.
- Published in:
- CIGFARO Journal, 2024, v. 24, n. 3, p. 48
- Publication type:
- Article
32
Immunotheraphy for Breast Cancer by Immune Check Point Inhibitors (Pd-1 & Pd-L1) using CNN for Image Analysis in Deep Learning.
- Published in:
- Grenze International Journal of Engineering & Technology (GIJET), 2024, v. 10, n. 2,Part 4, p. 5745
- By:
- Publication type:
- Article
33
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.733770
- By:
- Publication type:
- Article
34
Combination Strategies to Augment Immune Check Point Inhibitors Efficacy - Implications for Translational Research.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.559161
- By:
- Publication type:
- Article
35
Immune Check Point Inhibitors and Immune-Related Adverse Events in Small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.604227
- By:
- Publication type:
- Article
36
Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
37
Role of Inhibitory Check Point (CTLA-4) in Iraqi Women with Breast Cancer.
- Published in:
- Indian Journal of Forensic Medicine & Toxicology, 2021, v. 15, n. 3, p. 2337, doi. 10.37506/ijfmt.v15i3.15664
- By:
- Publication type:
- Article